ArticleClinical rheumatology2024

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.

Qi An et al.PubMed ↗Publisher ↗

No numbers read from the abstract.